Current Edition

The Increasing Importance of Clinical Education in the Rare and Orphan Disease Sector
Volume 11 Issue 4

The Increasing Importance of Clinical Education in the Rare and Orphan Disease Sector

Diagnosing and treating rare and orphan diseases remains one of the life science sector’s great challenges. This is compounded by small patient populations, which ar...
Continue Reading →
eConsent: Tearing Down Barriers to Oncology Trials
Volume 11 Issue 4

eConsent: Tearing Down Barriers to Oncology Trials

Despite more people surviving cancer than ever before, a staggering 9.6 million people worldwide died from cancer in 20181, making the need for new drugs a global pr...
Continue Reading →
Utilising Large Data Sets and Extended Trial Observations To Close the Alzheimer’s Evidence Gap
Volume 11 Issue 4

Utilising Large Data Sets and Extended Trial Observations To Close the Alzheimer’s Evidence Gap

One of the most widely recognised limitations of traditional randomised clinical trials (RCTs) is that the observation period and treatment courses reflect only a fr...
Continue Reading →
Exploring the Complexities of Importer of Record to Develop Effective Global Distribution Strategies
Volume 11 Issue 4

Exploring the Complexities of Importer of Record to Develop Effective Global Distribution Strategies

The pharmaceutical sector’s fundamental purpose of advancing human health and its ambition to deliver drugs to market as rapidly, safely and cost-effectively as poss...
Continue Reading →